Oxybutynin Chloride Extended Release
NDC 43353-322, Oxybutynin Chloride, tablet, extended release, from Aphena Pharma Solutions - Tennessee, LLC.
- Product NDC
- 43353-322
- Status
- Listed
- Labeler
- Aphena Pharma Solutions - Tennessee, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078503
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43353-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OXYBUTYNIN CHLORIDE15 mg/1
Pharmacologic classes
Cholinergic Muscarinic Antagonist [EPC]; Cholinergic Muscarinic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43353-322-16 | 43353032216 | 6000 TABLET, EXTENDED RELEASE in 1 BOTTLE (43353-322-16) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/02ff3be7-fc5c-4b91-8c67-ecdf6e19c42a
Use it
Look up 43353-322 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43353-322 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43353-322. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.